These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Use of immunotherapy in the treatment of malignant melanoma of the skin]. Kristensen E Ugeskr Laeger; 1976 Feb; 138(8):468-73. PubMed ID: 1258215 [No Abstract] [Full Text] [Related]
10. [Treatment of the complications occurring in BCG vaccine immunotherapy of patients with malignant neoplasms]. Grigorovich NA; Risina DIa; Nodel'son SE Vopr Onkol; 1984; 30(7):102-6. PubMed ID: 6464396 [TBL] [Abstract][Full Text] [Related]
11. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma. Peter HH; Deutschmann EM; Schultheis W; Deicher H Dev Biol Stand; 1977 Apr 13-15; 38():537-40. PubMed ID: 344106 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of melanoma with BCG: two fatalities following intralesional injection. McKhann CF; Hendrickson CG; Spitler LE; Gunnarsson A; Banerjee D; Nelson WR Cancer; 1975 Feb; 35(2):514-20. PubMed ID: 234291 [TBL] [Abstract][Full Text] [Related]
13. Primary inoculation tuberculosis after immunotherapy for malignant melanoma with BCG vaccine. Caplan SE; Kauffman CL J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):783-5. PubMed ID: 8912582 [No Abstract] [Full Text] [Related]
14. [Intralesion BCG vaccine therapy in cutaneous melanoma metastasis]. Wolf M; Menzel W Dermatol Monatsschr; 1978 Sep; 164(9):671-2. PubMed ID: 710658 [No Abstract] [Full Text] [Related]
15. [Experiences with immune BCG therapy of malignant melanoma]. Altmeyer P; Nödl F Dtsch Med Wochenschr; 1978 Jul; 103(30):1214. PubMed ID: 668562 [No Abstract] [Full Text] [Related]
16. [Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)]. Wätzig V; Knopf B Arch Geschwulstforsch; 1979; 49(2):140-5. PubMed ID: 475550 [TBL] [Abstract][Full Text] [Related]
17. [BCG-treatment of malignant melanoma]. Borberg H Internist (Berl); 1975 Oct; 16(10):482-5. PubMed ID: 1107254 [No Abstract] [Full Text] [Related]
18. [Intralesional application of BCG]. Kubíková M; Richter J; Hrivnáková J; Duchková H Cesk Dermatol; 1980 Aug; 55(4):280-1. PubMed ID: 7407971 [No Abstract] [Full Text] [Related]
19. [Unspecific, active BCG vaccination therapy in melanoma using a modified scarification procedure]. Wolf M; Menzel W; Keller G Dermatol Monatsschr; 1978 Apr; 164(4):302-3. PubMed ID: 668966 [No Abstract] [Full Text] [Related]
20. [Side effects of BCG immune therapy in 511 patients with malignant melanoma]. Schult C Hautarzt; 1984 Feb; 35(2):78-83. PubMed ID: 6706581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]